ROLE OF QUALITY OF LIFE IN HEALTH TECHNOLOGY ASSESSMENT AGENCY FINAL RECOMMENDATIONS: INSIGHTS AND LESSONS FROM REVIEW OF NICE TECHNOLOGY ASSESSMENT REPORTS (2019-2022)

被引：0
|
作者：
Aggarwal, S. [1 ]
Bela, A. [2 ]
Topaloglu, H. [2 ]
Kumar, S. [3 ]
Topaloglu, O. [1 ]
机构：
[1] NOVEL Hlth Strategies, Bethesda, MD USA
[2] NOVEL Hlth Strategies, Chevy Chase, MD USA
[3] NOVEL Hlth Strategies, Columbia, MD USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA83
引用
收藏
页码：S312 / S312
页数：1
相关论文
共 37 条
  • [31] Reports from the Swedish Council on Technology Assessment in Health Care (SBU) - Treatment of asthma and COPD: An evidence-based review
    不详
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2002, 18 (04) : 832 - 844
  • [32] Report from the Catalan Agency for Health Technology Assessment (CAHTA) - Review of the scientific evidence of the clinical and economic implications of resistance of enterococcus to vancomycin
    不详
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1999, 15 (04) : 767 - 769
  • [33] COPD and Asthma Disease-specific Health-related Quality of Life Scales and Their Applications in Health Technology Assessment and in China: Literature Review
    Gong, Shiyi
    Hu, Hao
    Zhang, Yangxian
    Xie, Feng
    Yang, Ting
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [34] HEALTH OUTCOMES AND ECONOMICS RESEARCH FOR REGENERATIVE MEDICINE AND CELLULAR THERAPIES: LESSONS FROM A MULTI-MARKET HEALTH TECHNOLOGY ASSESSMENT AND REIMBURSEMENT REVIEW
    Faulkner, E. C.
    Fernandez, M.
    Spinner, D. S.
    VALUE IN HEALTH, 2011, 14 (07) : A337 - A338
  • [35] Is health-related quality of life sufficiently addressed in trials for breast cancer treatments? An assessment based on reimbursement opinions from the French health technology assessment body, 2009-2023
    Kyheng, Maeva
    Tonoli, Helene
    Supah, Nicolas
    Franca, Lionel Riou
    Massol, Jacques
    JOURNAL OF CANCER POLICY, 2024, 42
  • [36] TARGETED LITERATURE REVIEW OF THE USE OF REAL-WORLD EVIDENCE FROM SINGLE REAL-WORLD DATA SOURCES AND IN META-ANALYSES: METHODOLOGIES AND RECOMMENDATIONS FROM HEALTH TECHNOLOGY ASSESSMENT BODIES
    Martin, C.
    Diawara, K.
    Jaiswal, A. K.
    Gamburg, R.
    Miller, J.
    Park, C.
    Ranjan, N.
    Mehta, A. M.
    Tamminina, D.
    Shah, T.
    Schmerold, L.
    Hood, D.
    VALUE IN HEALTH, 2024, 27 (06) : S14 - S15
  • [37] Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers' Submissions and a Comparison Between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses (Aug, 10. 1007/s41669- 024- 00511-9, 2024)
    Fashami, Fatemeh Mirzayeh
    Tarride, Jean-Eric
    Sadeghirad, Behnam
    Hariri, Kimia
    Peyrovinasab, Amirreza
    Levine, Mitchell
    PHARMACOECONOMICS-OPEN, 2024, 8 (06) : 963 - 965
1234